PRODUCT FOCUS
#9158
Rapid, In-office Test to Help Diagnose Dry Eye
RPS®’s InflammaDry® – a rapid, disposable, in-office test to aid in the diagnosis of dry eye disease – has been
FDA cleared. InflammaDry is the first and only, rapid, in-office test to detect MMP-9, an inflammatory marker
that is elevated in the tears of patients with dry eye disease. Using a small tear sample, the simple, four-step
InflammaDry process takes less than two minutes to complete and provides results in ten minutes.
View Brochures, Videos & More at: POR.io (Search #9158)
Innovative User-friendly EHR
#9159
Amazing Charts costs just $1,995 per provider
(one-time license), which includes the first
year of e-prescribing and updates. Suppor